• OPEN AN ACCOUNT
Indian Indices
Nifty
25,003.05 252.15
(1.02%)
Sensex
82,188.99 746.95
( 0.92%)
Bank Nifty
56,578.40 817.55
( 1.47%)
Nifty IT
37,294.85 186.90
( 0.50%)
Global Indices
Nasdaq
42,779.54 438.80
(1.04%)
Dow Jones
6,020.48 60.18
(1.01%)
Hang Seng
37,687.53 133.04
(0.35%)
Nikkei 225
8,837.91 26.87
(0.30%)
Forex
USD-INR
85.77 -0.09
(-0.10%)
EUR-INR
97.89 0.03
(0.03%)
GBP-INR
116.15 -0.09
(-0.08%)
JPY-INR
0.59 0.00
(-0.69%)

EQUITY - MARKET SCREENER

Themis Medicare Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
530199
INE083B01024
31.1725595
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
THEMISMED
52.1
1246.68
EPS(TTM)
Face Value()
Div & Yield %
2.6
1
0
 

HFCL Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation
May 23,2025
In terms of Regulation 30 read with Para A of Part A of Schedule III to the SEBI Listing Regulations we hereby submit a copy of the Earnings Presentation inter-alia on the Audited Financial Results of the Company for the 4th Quarter and Financial Year ended March 31 2025 both on Standalone and Consolidated basis to be discussed during the Earnings Call scheduled to be held on Friday May 23 2025 at 04:00 p.m. It may be noted that the Board of Directors of the Company has considered and approved the aforesaid Financial Results of the Company in its meeting held on May 22 2025.